<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> Mar 2026 - Rilemo completes the industrialization of the product’s functional components and starts the collaboration with Creanova, advancing the transition from device development to final product readiness and strengthening the company’s path toward scalable manufacturing
</aside>
<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> Feb 2026 - Rilemo participates in the first International Conference on Medical Microwave Imaging Applications (ICMWIA) in Lisbon, bringing its experience to the field and collaborating with peer groups to drive medical MWI toward broader clinical recognition and adoption
</aside>
<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> Nov 2025 - Rilemo takes part in MEDICA 2025 to present its next steps and engages with international medtech stakeholders, reinforcing the company’s positioning within the global shift toward point-of-care innovation
</aside>
<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> July 2025 - Rilemo ****secures ~€500k through a SAFE round backed by Business Angels, supporting core value-creation areas including regulatory strategy, pricing and financial planning
</aside>
<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> May 2025 - Rilemo’s final pre-industrialization prototype is validated on neurological human cadavers (ex-vivo) at the **Trecchi Lab Institute** (Cremona, IT)
</aside>
<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> Mar 2025 - Rilemo ****completes a clinical staff survey with 300+ in person interviews to validate market need & define the long term strategy at the European Congress of Radiology (ECR25)
</aside>

Creanova, Rilemo’s CDMO partner

Rilemo at ICMWIA 2026 - LinkedIn post

MEDICA 2025 participation - LinkedIn post

Executed SAFE documentation

Rilemo team together with Jody Capitanio, neurosurgeon and Clinical Advisor to Rilemo

LinkedIn post following the ECR2025 congress
<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> Dec 2024 - Rilemo ****(ex. Previeni) wins **€50.000 Grant from Fondazione UNIMI during Seed4Innovation
</aside>

IRCCS Galeazzi LinkedIn post link
<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> Nov 2024 - Rilemo demonstrates fluid detection capability compared with a CT scan in hospital settings with bovine animal ex-vivo samples
</aside>

Publication accepted at European Radiology Experimental
<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> Sep 2024 - Rilemo ****enters into Bocconi 4 Innovation (B4i) Acceleration ****program securing a €50.000 Investment and incorporating as Rilemo S.r.l.
</aside>

Bocconi 4 Innovation announcement LinkedIn post link
<aside> <img src="/icons/arrow-left-basic_blue.svg" alt="/icons/arrow-left-basic_blue.svg" width="40px" /> Jul 2024 - Rilemo ****(ex. Previeni) wins €10.000 Grant during the ****Unfold AI competition by Dock3
</aside>

<aside> <img src="/icons/arrow-right-basic_blue.svg" alt="/icons/arrow-right-basic_blue.svg" width="40px" /> Jun 2024 - Rilemo ****completes a USA and East Europe tour to analyse the market state and future expansion strategy
</aside>
